Cytomegalovirus (CMV)
Clinical trials for Cytomegalovirus (CMV) explained in plain language.
Never miss a new study
Get alerted when new Cytomegalovirus (CMV) trials appear
Sign up with your email to follow new studies for Cytomegalovirus (CMV), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a CMV-Based vaccine teach the body to fight HIV?
Vaccine Not yet recruitingThis phase 1 trial tests a higher dose of the experimental HIV vaccine VIR-1388 in about 12 adults aged 18 to 55 who already carry cytomegalovirus (CMV). The vaccine uses a weakened CMV virus to deliver HIV proteins, aiming to trigger a strong immune response. Participants receiv…
Matched conditions: CYTOMEGALOVIRUS (CMV)
Phase 1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Vaccine
Last updated Sep 05, 2026 00:00 UTC
-
New trial aims to stop CMV eye inflammation from returning
Disease control Not yet recruitingThis study tests whether oral valganciclovir or ganciclovir eye drops can reduce the virus causing eye inflammation and prevent flare-ups. About 117 adults with CMV anterior uveitis will receive either antiviral treatment or placebo for 7 days, then some continue for 12 months. T…
Matched conditions: CYTOMEGALOVIRUS (CMV)
Phase 2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC